Company

Pfizer CEO Denies Licensing Paxlovid to Chinese Generics Firms

Company

Legend Biotech Receives Nasdaq Notice Regarding Listing Compliance

CompanyDrug

Jiangxi Jemincare’s JMKX003142 Gets FDA Nod for Clinical Study

CompanyDrug

Pfizer’s Paxlovid Excluded from China’s NRDL Amid Price Dispute

Policy / Regulatory

China Strengthens COVID-19 Prevention and Control in Rural Areas

CompanyDrug

Eli Lilly’s Donanemab Set to Gain Breakthrough Therapy Designation in China

CompanyDeals

Changzhou Sifary Medtech Secures Series B Funding for Global Expansion

CompanyDrug

Suzhou Thery’s Generic Nilotinib Approved by China’s NMPA

CompanyDrug

Zhifei Biological Products’ BCG Vaccine Filing Accepted by China’s NMPA

CompanyDrug

Yantai Dongcheng Pharma Gets FDA Go-Ahead for 177Lu-LNC1004 Clinical Trial

CompanyDeals

VivaVision Biotech Partners with Everads Therapy for Retinal Disease Therapies

CompanyDeals

Shenzhen-Based Rhegen Bio Raises RMB 100 Million in Pre-Series B Round